Target intelligence / Profile preview

Lon protease homolog, mitochondrial (LONP1)

Target
LONP1
Molecular classification
Enzyme, Protease, Serine protease, ATP-dependent protease, AAA+ ATPase, Chaperone
01

Overview

Lon protease homolog, mitochondrial (LONP1) is a highly conserved, nuclear-encoded ATP-dependent serine protease located within the mitochondrial matrix. As a member of the AAA+ (ATPases Associated with diverse cellular Activities) superfamily, it plays a critical role in mitochondrial protein quality control by selectively degrading misfolded, unassembled, or oxidatively damaged proteins, such as aconitase and TFAM. Beyond its proteolytic function, LONP1 acts as a molecular chaperone to facilitate the folding and assembly of mitochondrial protein complexes and binds to mitochondrial DNA (mtDNA) to regulate its maintenance and transcription. In the context of disease, LONP1 is frequently overexpressed in various cancers, where it supports cell survival under hypoxic and oxidative stress conditions, making it a promising therapeutic target. Conversely, loss-of-function mutations in LONP1 are the primary cause of CODAS syndrome, a rare multisystem developmental disorder. Small molecule inhibitors, such as the synthetic triterpenoid CDDO and its derivative CDDO-Me (Bardoxolone methyl), have been shown to directly inhibit LONP1, leading to the accumulation of mitochondrial protein aggregates and the induction of apoptosis in cancer cells.

Other names
LONP1LONLONPLonHSPIM1PRSS15hLONCODASSLon peptidase 1, mitochondrialLon protease-like proteinSerine protease 15Mitochondrial ATP-dependent protease Lon
02

Mechanism of action

Inhibition of the proteolytic activity or the ATPase activity of LONP1, which prevents the degradation of damaged proteins and leads to the accumulation of mitochondrial protein aggregates, ultimately triggering apoptosis in cancer cells.

03

Biological functions

ProteolysisProtein quality controlChaperone activityMitochondrial DNA maintenanceMitochondrial gene expression regulationStress responseMitophagy regulation
04

Disease associations

CancerCODAS syndromeAgingNeurodegenerative diseaseCardiovascular diseaseSarcopenia
05

Safety considerations

Essentiality for life (homozygous deletion is embryonic lethal)Potential for systemic mitochondrial toxicityRisk of developmental defects (CODAS syndrome)
06

Interacting drugs

CDDO (2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid)

2 more in the full profile.

07

Biomarkers

Aconitase levelsTFAM levelsMitochondrial protein aggregatesReactive oxygen species (ROS) levelsMitochondrial membrane potential

Beyond the preview

Go deeper on Lon protease homolog, mitochondrial (LONP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lon protease homolog, mitochondrial (LONP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call